315 related articles for article (PubMed ID: 32017931)
1. Human artificial chromosomes for pluripotent stem cell-based tissue replacement therapy.
Sinenko SA; Ponomartsev SV; Tomilin AN
Exp Cell Res; 2020 Apr; 389(1):111882. PubMed ID: 32017931
[TBL] [Abstract][Full Text] [Related]
2. Pluripotent stem cell-based gene therapy approach: human de novo synthesized chromosomes.
Sinenko SA; Ponomartsev SV; Tomilin AN
Cell Mol Life Sci; 2021 Feb; 78(4):1207-1220. PubMed ID: 33011821
[TBL] [Abstract][Full Text] [Related]
3. Human Alphoid
Ponomartsev SV; Sinenko SA; Skvortsova EV; Liskovykh MA; Voropaev IN; Savina MM; Kuzmin AA; Kuzmina EY; Kondrashkina AM; Larionov V; Kouprina N; Tomilin AN
Cells; 2020 Apr; 9(4):. PubMed ID: 32260189
[TBL] [Abstract][Full Text] [Related]
4. Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes.
Tedesco FS
Chromosome Res; 2015 Feb; 23(1):135-41. PubMed ID: 25596829
[TBL] [Abstract][Full Text] [Related]
5. Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy.
Benedetti S; Uno N; Hoshiya H; Ragazzi M; Ferrari G; Kazuki Y; Moyle LA; Tonlorenzi R; Lombardo A; Chaouch S; Mouly V; Moore M; Popplewell L; Kazuki K; Katoh M; Naldini L; Dickson G; Messina G; Oshimura M; Cossu G; Tedesco FS
EMBO Mol Med; 2018 Feb; 10(2):254-275. PubMed ID: 29242210
[TBL] [Abstract][Full Text] [Related]
6. Complete genetic correction of ips cells from Duchenne muscular dystrophy.
Kazuki Y; Hiratsuka M; Takiguchi M; Osaki M; Kajitani N; Hoshiya H; Hiramatsu K; Yoshino T; Kazuki K; Ishihara C; Takehara S; Higaki K; Nakagawa M; Takahashi K; Yamanaka S; Oshimura M
Mol Ther; 2010 Feb; 18(2):386-93. PubMed ID: 19997091
[TBL] [Abstract][Full Text] [Related]
7. Transfer of human artificial chromosome vectors into stem cells.
Oshimura M; Katoh M
Reprod Biomed Online; 2008 Jan; 16(1):57-69. PubMed ID: 18252049
[TBL] [Abstract][Full Text] [Related]
8. Developing de novo human artificial chromosomes in embryonic stem cells using HSV-1 amplicon technology.
Moralli D; Monaco ZL
Chromosome Res; 2015 Feb; 23(1):105-10. PubMed ID: 25657030
[TBL] [Abstract][Full Text] [Related]
9. Transfer of Synthetic Human Chromosome into Human Induced Pluripotent Stem Cells for Biomedical Applications.
Sinenko SA; Skvortsova EV; Liskovykh MA; Ponomartsev SV; Kuzmin AA; Khudiakov AA; Malashicheva AB; Alenina N; Larionov V; Kouprina N; Tomilin AN
Cells; 2018 Dec; 7(12):. PubMed ID: 30544831
[TBL] [Abstract][Full Text] [Related]
10. [Challenge toward gene-therapy using iPS cells for Duchenne muscular dystrophy].
Oshimura M; Kazuki Y; Uno N
Rinsho Shinkeigaku; 2012; 52(11):1139-42. PubMed ID: 23196542
[TBL] [Abstract][Full Text] [Related]
11. Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy.
Tedesco FS; Hoshiya H; D'Antona G; Gerli MF; Messina G; Antonini S; Tonlorenzi R; Benedetti S; Berghella L; Torrente Y; Kazuki Y; Bottinelli R; Oshimura M; Cossu G
Sci Transl Med; 2011 Aug; 3(96):96ra78. PubMed ID: 21849666
[TBL] [Abstract][Full Text] [Related]
12. An induced pluripotent stem cell-mediated and integration-free factor VIII expression system.
Yakura Y; Ishihara C; Kurosaki H; Kazuki Y; Komatsu N; Okada Y; Doi T; Takeya H; Oshimura M
Biochem Biophys Res Commun; 2013 Feb; 431(2):336-41. PubMed ID: 23291180
[TBL] [Abstract][Full Text] [Related]
13. DYS-HAC-iPS cells: the combination of gene and cell therapy to treat duchenne muscular dystrophy.
Park IH
Mol Ther; 2010 Feb; 18(2):238-40. PubMed ID: 20125163
[No Abstract] [Full Text] [Related]
14. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
15. Stable maintenance of de novo assembled human artificial chromosomes in embryonic stem cells and their differentiated progeny in mice.
Liskovykh M; Ponomartsev S; Popova E; Bader M; Kouprina N; Larionov V; Alenina N; Tomilin A
Cell Cycle; 2015; 14(8):1268-73. PubMed ID: 25695642
[TBL] [Abstract][Full Text] [Related]
16. Engineering of human induced pluripotent stem cells via human artificial chromosome vectors for cell therapy and disease modeling.
Kazuki Y; Uno N; Abe S; Kajitani N; Kazuki K; Yakura Y; Sawada C; Takata S; Sugawara M; Nagashima Y; Okada A; Hiratsuka M; Osaki M; Ferrari G; Tedesco FS; Nishikawa S; Fukumoto K; Takayanagi SI; Kunisato A; Kaneko S; Oshimura M; Tomizuka K
Mol Ther Nucleic Acids; 2021 Mar; 23():629-639. PubMed ID: 33552683
[TBL] [Abstract][Full Text] [Related]
17. Refined human artificial chromosome vectors for gene therapy and animal transgenesis.
Kazuki Y; Hoshiya H; Takiguchi M; Abe S; Iida Y; Osaki M; Katoh M; Hiratsuka M; Shirayoshi Y; Hiramatsu K; Ueno E; Kajitani N; Yoshino T; Kazuki K; Ishihara C; Takehara S; Tsuji S; Ejima F; Toyoda A; Sakaki Y; Larionov V; Kouprina N; Oshimura M
Gene Ther; 2011 Apr; 18(4):384-93. PubMed ID: 21085194
[TBL] [Abstract][Full Text] [Related]
18. An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells.
Haridhasapavalan KK; Borgohain MP; Dey C; Saha B; Narayan G; Kumar S; Thummer RP
Gene; 2019 Feb; 686():146-159. PubMed ID: 30472380
[TBL] [Abstract][Full Text] [Related]
19. Highly Efficient Microcell-Mediated Transfer of HACs Containing a Genomic Region of Interest into Mammalian Cells.
Liskovykh M; Larionov V; Kouprina N
Curr Protoc; 2021 Sep; 1(9):e236. PubMed ID: 34491634
[TBL] [Abstract][Full Text] [Related]
20. A new generation of human artificial chromosomes for functional genomics and gene therapy.
Kouprina N; Earnshaw WC; Masumoto H; Larionov V
Cell Mol Life Sci; 2013 Apr; 70(7):1135-48. PubMed ID: 22907415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
